Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247971 · ClinicalTrials.gov registry record
Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 16
- Enrollment target
NCT04247971: Completed study, sponsored by Duke University.
NCT04247971 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04247971 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to gain understanding of mechanisms whereby bariatric surgery modulates pulmonary inflammation and pulmonary microbiome composition and how these changes direct the pathobiology of human obese asthma.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Sputum collection
- PROCEDURE Pulmonary function test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2023-02-09 |
What the finished NCT04247971 record still lists
NCT04247971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT04247971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04247971 about?
NCT04247971 is a clinical study titled "Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma". The purpose of this study is to gain understanding of mechanisms whereby bariatric surgery modulates pulmonary inflammation and pulmonary microbiome composition and how these changes direct the pathobiology of human obese asthma.
What is the current status of trial NCT04247971?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-04-30. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT04247971?
The interventions under investigation include: Blood draw (PROCEDURE), Sputum collection (PROCEDURE), Pulmonary function test (PROCEDURE).
Who is sponsoring clinical trial NCT04247971?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI